Evaluation of Flap Tissue Viability by F-18 FDG PET/CT

Nuclear Medicine and Molecular Imaging

Volumn 48, Issue 3, 2014, Pages 241-243

  Lee, Inki ^a   Kang, Seo Young ^a   Heo, Chan Yeong ^a   Lee, Ho Young ^a   Kim, Sang Eun ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Fluorine 18 fluorodeoxyglucose; Myocutaneous flap; Positron emission tomography; Tissue viability

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEBRIDEMENT; FOLLOW UP; GRAFT FAILURE; GRAFT NECROSIS; GRAFT SURVIVAL; HUMAN; LUNG RESECTION; MALE; METABOLIC DISORDER; MIDDLE AGED; PRIORITY JOURNAL; THORAX WALL DEFECT; TISSUE FLAP; TRANSVERSE RECTUS ABDOMINIS MUSCULOCUTANEOUS FLAP; WOUND CLOSURE;

EID: 84906771841     PISSN: 18693474     EISSN: 18693482     Source Type: Journal    
DOI: 10.1007/s13139-014-0278-0     Document Type: Article

References (19)

1. Geis S, Schreml S, Lamby P, Obed A, Jung EM, Nerlich M, et al. Postoperative assessment of free skin flap viability by transcutaneous pO2 measurement using dynamic phosphorescence imaging. Clin Hemorheol Microcirc. 2009;43(1-2): 11-8.
2. Kroll SS, Schusterman MA, Reece GP, Miller MJ, Evans GR, Robb GL, et al. Choice of flap and incidence of free flap success. Plast Reconstr Surg. 1996;98(3): 459-63.
3. Repež A, Oroszy D, Arnež ZM. Continuous postoperative monitoring of cutaneous free flaps using near infrared spectroscopy. J Plast Reconstr Aesthet Surg. 2008;61(1): 71-7.
4. Top H, Sarikaya A, Aygit AC, Benlier E, Kiyak M. Review of monitoring free muscle flap transfers in reconstructive surgery: role of 99mTc sestamibi scintigraphy. Nucl Med Commun. 2006;27(1): 91-8.
5. Disa JJ, Cordeiro PG, Hidalgo DA. Efficacy of conventional monitoring techniques in free tissue transfer: an 11-year experience in 750 consecutive cases. Plast Reconstr Surg. 1999;104(1): 97-101.
6. Smith GT, Wilson TS, Hunter K, Besozzi MC, Hubner KF, Reath DB, et al. Assessment of skeletal muscle viability by PET. J Nucl Med. 1995;36(8): 1408-14.
7. Luu Q, Farwell DG. Advances in free flap monitoring: have we gone too far? Curr Opin Otolaryngol Head Neck Surg. 2009;17(4): 267-9.
8. Schrey AR, Kinnunen IA, Grenman RA, Minn HR, Aitasalo KM. Monitoring microvascular free flaps with tissue oxygen measurement and PET. Eur Arch Otorhinolaryngol. 2008;265 Suppl 1: S105-13.
9. Sarikaya A, Aygit AC. Combined 99mTc MDP bone SPECT and 99mTc sestamibi muscle SPECT for assessment of bone regrowth and free muscle flap viability in an electrical burn of scalp. Burns. 2003;29(4): 385-8.
10. Tukiainen E. Chest wall reconstruction after oncological resections. Scand J Surg. 2013;102(1): 9-13.
11. Khalil HH, El-Ghoneimy A, Farid Y, Ebeid W, Afifi A, Elaffandi A, et al. Modified vertical rectus abdominis musculocutaneous flap for limb salvage procedures in proximal lower limb musculoskeletal sarcomas. Sarcoma. 2008;2008: 781408.
12. Glatt BS, Disa JJ, Mehrara BJ, Pusic AL, Boland P, Cordeiro PG. Reconstruction of extensive partial or total sacrectomy defects with a transabdominal vertical rectus abdominis myocutaneous flap. Ann Plast Surg. 2006;56(5): 526-30. discussion 30-1.
13. Siegel ME, Stewart CA, Wagner Jr FW, Sakimura I. An index to measure the healing potential of ischaemic ulcers using Thallium 201. Prosthetics Orthot Int. 1983;7(2): 67-8.
14. Siegel ME, Stewart CA, Wagner W, Sakimura I. A new objective criterion for determining, noninvasively, the healing potential of an ischemic ulcer. J Nucl Med. 1981;22(2): 187-9.
15. Ohta T. Noninvasive technique using thallium-201 for predicting ischaemic ulcer healing of the foot. Br J Surg. 1985;72(11): 892-5.
16. Labbe R, Lindsay T, Walker PM. The extent and distribution of skeletal muscle necrosis after graded periods of complete ischemia. J Vasc Surg. 1987;6(2): 152-7.
17. Matsunari I, Taki J, Nakajima K, Tonami N, Hisada K. Myocardial viability assessment using nuclear imaging. Ann Nucl Med. 2003;17(3): 169-79.
18. El-Haddad G, Zhuang H, Gupta N, Alavi A. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med. 2004;34(4): 313-29.
19. Aigner RM, Schultes G, Wolf G, Yamashita Y, Sorantin E, Karcher H. 18 F-FDG PET: early postoperative period of oro-maxillo-facial flaps. Nuklearmedizin Nucl Med. 2003;42(5): 210-4.